Flow cytometric analysis of lymphocyte subpopulations and Th1/Th2 balance in patients with polymyositis and dermatomyositis

Internal Medicine

Volumn 47, Issue 18, 2008, Pages 1593-1599

  Ishii, Wataru ^a,c   Matsuda, Masayuki ^a   Shimojima, Yasuhiro ^a   Itoh, Susumu ^b   Sumida, Takayuki ^c   Ikeda, Shu Ichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Dermatomyositis; Flow cytometry; Intracytoplasmic cytokine; Polymyositis; Th1 Th2 balance

Indexed keywords

CD19 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 4; PREDNISOLONE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HELPER CELL; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; OUTCOME ASSESSMENT; PERIPHERAL LYMPHOCYTE; POLYMYOSITIS; REMISSION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CYTOKINES; DERMATOMYOSITIS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; TH1 CELLS; TH2 CELLS;

EID: 56349134839     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0967     Document Type: Article

References (24)

1. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. 2: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 16: 209-215, 1984.
2. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. 3: Immunoelectron microscopic aspects of cell-mediated muscle fiber injury. Ann Neurol 19: 112-125, 1986.
3. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. 5: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells. Ann Neurol 23: 493-499, 1988.
4. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class 1 antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 20: 224-231, 1989.
5. Dalakas MC. Inflammatory disorders of muscle: Progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17: 561-567, 2004.
6. Engel AG, Arahata K. Mononuclear cells in myopathies: Quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 17: 704-721, 1986.
7. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. 1: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16: 193-208, 1984.
8. Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 325: 1487-1498, 1991.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 292: 344-347, 1975.
10. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 362: 971-982, 2003.
11. Aleksza M, Szegedi A, Antal-Szalmas P, et al. Altered cytokine expression of peripheral blood lymphocytes in polymyositis and dermatomyositis. Ann Rheum Dis 64: 1485-1489, 2005.
12. Ishida T, Matsumoto Y, Ohashi M, Sasaki R. Analysis of lymphocyte subpopulations in peripheral blood in adult and juvenile cases of dermatomyositis. J Dermatol 20: 30-34, 1993.
13. Kikuchi Y, Koarada S, Tada Y, et al. Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells. Ann Rheum Dis 60: 1137-1140, 2001.
14. Thorley-Lawson DA, Nadler LM, Bhan AK, Schooley BT. BLAST-2 (EBVCS), an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. J Immunol 134: 3007-3012, 1985.
15. Behan WMH, Behan PO, Micklem HS, Durward WF. Abnormalities of lymphocyte subsets in polymyositis. Br Med J 287: 181-182, 1983.
16. Lyer V, Lawton AR, Fenichel GM. T cell subsets in polymyositis. Ann Neurol 13: 452-453, 1983.
17. Iannone F, Cauli A, Yanni G, et al. T-lymphocyte immunopheno typing in polymyositis and dermatomyositis. Br J Rheumatol 35: 839-845, 1996.
18. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25 high regulatory cells in human peripheral blood. J Immunol 167: 1245-1253, 2001.
19. De Bleecker JL, Engel AG. Immunocytochemical study of CD45 T cell isoforms in inflammatory myopathies. Am J Pathol 146: 1178-1187, 1995.
20. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 27: 343-356, 1990.
21. Pietschmann P, Cush JJ, Lipsky PE, Oppenheimer-Marks N. Identification of subsets of human T cells capable of enhanced transendothelial migration. J Immunol 149: 1170-1178, 1992.
22. Hagiwara E, Gourley MF, Lee S, Klinman DM. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 39: 379-385, 1996.
23. Nagy G, Pallinger E, Antal-Szalmas P, et al. Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus. Immunol Lett 74: 207-210, 2000.
24. Hagiwara E, Adams EM, Plotz PH, Klinman DM. Abnormal numbers of cytokine producing cells in patients with polymyositis and dermatomyositis. Clin Exp Rheumatol 14: 485-491, 1996.